Opdualag® (nivolumab and relatlimab-rmbw)
for Skin Cancer

Opdualag (nivolumab and relatlimab-rmbw) is used to treat adults and children aged 12 and older with melanoma that has spread or cannot be removed by surgery. As an immunotherapy, Opdualag works by activating the body's immune system to target and attack cancer cells.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Skin Cancer